You are here

Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Phoenix, Arizona, United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Post-Herpetic Neuralgia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of PHN with pain present for at least three months after the healing of a
Herpes Zoster skin lesion.

- Subjects must have completed the Daily Pain Rating Scale in the electronic diary at
least 4 times during screening and have an average daily pain rating score of greater
than or equl to 4 during the 7 +/- 3 days prior to randomization (Visit 2).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of neurolytic or neurosurgical therapy for PHN.

- Presence of any severe pain associated with conditions other than PHN that may
confound the assessment or self-evaluation of the pain due to PHN.

NCT00159666
Pfizer
Completed
Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now